FGL1 and neoplasm: As expected, we observed an increase in the levels of markers that are important for immune responses and inflammation (Saa1, Saa2, Lcn-2, Ltf, and Orosomucoid-2) and initiating and promoting tumor growth (Ighg1, Scube3, and Fgl1).